Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) Price Target at $78.08

Key Points

• Henry Schein, Inc. has received a consensus recommendation of "Hold" from 12 brokerages, including 8 hold ratings and 4 buy ratings.
• The average 1-year price target for Henry Schein stocks is $78.08, with recent price target adjustments by various analysts indicating a general decrease.
• Henry Schein reported a net margin of 3.21% and earnings of $1.15 per share for the latest quarter, slightly outperforming analyst estimates of $1.11.

Shares of Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) have received an average rating of "Hold" from the twelve research firms that are covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among analysts that have covered the stock in the last year is $78.08.

Several equities analysts have recently issued reports on HSIC shares. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Piper Sandler decreased their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Stifel Nicolaus restated a "hold" rating and set a $75.00 target price (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Robert W. Baird reiterated a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Finally, Barrington Research lowered their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th.

Hedge Funds Weigh In On Henry Schein

A number of large investors have recently bought and sold shares of the company. Envestnet Asset Management Inc. boosted its position in Henry Schein by 103.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 91,299 shares of the company's stock worth $6,669,000 after acquiring an additional 46,357 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in Henry Schein by 4.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 33,421 shares of the company's stock worth $2,441,000 after acquiring an additional 1,555 shares during the last quarter. Wealthfront Advisers LLC boosted its position in Henry Schein by 8.7% during the 2nd quarter. Wealthfront Advisers LLC now owns 11,956 shares of the company's stock worth $873,000 after acquiring an additional 959 shares during the last quarter. Lee Danner & Bass Inc. boosted its position in Henry Schein by 44.6% during the 2nd quarter. Lee Danner & Bass Inc. now owns 52,335 shares of the company's stock worth $3,823,000 after acquiring an additional 16,150 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in Henry Schein by 24.8% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 6,272 shares of the company's stock worth $458,000 after acquiring an additional 1,247 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Trading Up 0.5%

Shares of Henry Schein stock traded up $0.33 during trading on Wednesday, hitting $67.98. 1,557,873 shares of the company were exchanged, compared to its average volume of 1,623,685. The firm has a market capitalization of $8.27 billion, a P/E ratio of 21.24, a price-to-earnings-growth ratio of 2.19 and a beta of 0.82. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49. The firm's fifty day moving average price is $71.62 and its 200 day moving average price is $71.33. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company's revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.10 EPS. As a group, sell-side analysts expect that Henry Schein will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.